These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30527237)

  • 1. Nodal volume as a prognostic factor in locally advanced head and neck cancer: Identifying candidates for elective neck dissection after chemoradiation with IGRT from a single institutional prospective series from the Indian subcontinent.
    Dua B; Chufal KS; Bhatnagar A; Thakwani A
    Oral Oncol; 2018 Dec; 87():179-185. PubMed ID: 30527237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.
    Fatehi KS; Thiagarajan S; Dhar H; Purandare N; DCruz AK; Chaukar D; Laskar SG; Prabhash K; Rangarajan V
    Auris Nasus Larynx; 2019 Aug; 46(4):599-604. PubMed ID: 30594328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Maguire PD; Neal CR; Hardy SM; Schreiber AM
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
    Sher DJ; Pham NL; Shah JL; Sen N; Williams KA; Subramaniam RM; Moore W; Chorley R; Ahn C; Khan SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):932-940. PubMed ID: 33127491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
    Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
    Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nodal response to chemoselection predicts the risk of recurrence following definitive chemoradiotherapy for pharyngeal cancer.
    Hanai N; Ozawa T; Hirakawa H; Suzuki H; Fukuda Y; Hasegawa Y
    Acta Otolaryngol; 2014 Aug; 134(8):865-71. PubMed ID: 25022795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target delineation for postoperative treatment of head and neck cancer.
    Evans M; Beasley M
    Oral Oncol; 2018 Nov; 86():288-295. PubMed ID: 30409314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of prophylactic retropharyngeal lymph node irradiation in patients with locally advanced head and neck cancer.
    Nguyen NP; Vock J; Vinh-Hung V; Almeida F; Ewell L; Betz M; Jang S; Vo RA; Dutta S; Godinez J; Karlsson U; Chi A
    BMC Cancer; 2012 Jun; 12():253. PubMed ID: 22708791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of primary tumor volume and metastatic lymph node volume in response to curative effect of definitive radiotherapy for locally advanced head and neck cancer.
    Mao W; Zhang T; Li L; Peng S; Gong H; Li M
    Eur J Med Res; 2024 Feb; 29(1):98. PubMed ID: 38311769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.
    Nevens D; Vantomme O; Laenen A; Hermans R; Nuyts S
    Br J Radiol; 2016 Dec; 89(1068):20160492. PubMed ID: 27710014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Cancer in the Indian Subcontinent-Survival Outcomes and Risk Factors with Primary Surgery.
    Thakar A; Thakur R; Kakkar A; Malhotra RK; Singh CA; Sikka K; Kumar R; Pramanik R; Biswas A; Bhalla AS; Bhaskar S; Sharma A
    Laryngoscope; 2021 Oct; 131(10):2254-2261. PubMed ID: 33797083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.
    Huang PW; Lin CY; Hsieh CH; Hsu CL; Fan KH; Huang SF; Liao CT; Ng SK; Yen TC; Chang JT; Wang HM
    Biomed J; 2018 Apr; 41(2):129-136. PubMed ID: 29866601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.
    Chen WY; Chen TC; Lai SF; Liang TH; Huang BS; Wang CW
    PLoS One; 2019; 14(12):e0225962. PubMed ID: 31794576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.